Literature DB >> 10515996

Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus.

A Fassati1, S P Goff.   

Abstract

To examine the early events in the life cycle of Moloney murine leukemia virus (MoMLV), we analyzed the intracellular complexes mediating reverse transcription. Partial purification of the reverse transcription complexes (RTCs) by equilibrium density fractionation and velocity sedimentation indicated that three distinct species of intracellular complexes are formed shortly after cell infection. Only one of these species is able to start and complete reverse transcription in the cell cytoplasm. This RTC is composed of at least the viral genome, capsid, integrase, and reverse transcriptase proteins. The RTC becomes permeable to micrococcal nuclease but not to antibodies. Shortly after initiation of reverse transcription, the viral strong stop DNA within the RTC is protected from nuclease digestion. The sedimentation velocity of the RTC decreases during reverse transcription. After entry into the nucleus, most capsid proteins are lost from the RTC and its sedimentation velocity decreases further.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10515996      PMCID: PMC112922          DOI: 10.1128/JVI.73.11.8919-8925.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Point mutations in the P30 domain of the gag gene of Moloney murine leukemia virus.

Authors:  H W Hsu; P Schwartzberg; S P Goff
Journal:  Virology       Date:  1985-04-15       Impact factor: 3.616

2.  A previously unidentified host protein protects retroviral DNA from autointegration.

Authors:  M S Lee; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

3.  Localization of RNA tumor virus polypeptides. I. Isolation of further virus substructures.

Authors:  D P Bolognesi; R Luftig; J H Shaper
Journal:  Virology       Date:  1973-12       Impact factor: 3.616

4.  Some characteristics of an isolated group antigen common to most strains of murine leukemia virus.

Authors:  M A Fink; L R Sibal; N A Wivel; C A Cowles; T E O'Conner
Journal:  Virology       Date:  1969-04       Impact factor: 3.616

5.  Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.

Authors:  S Goff; P Traktman; D Baltimore
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

6.  The core of murine leukemia virus requires phosphate for structural stability.

Authors:  R K Durbin; J S Manning
Journal:  Virology       Date:  1982-01-15       Impact factor: 3.616

7.  Tables for estimating sedimentation through linear concentration gradients of sucrose solution.

Authors:  C R McEwen
Journal:  Anal Biochem       Date:  1967-07       Impact factor: 3.365

8.  Footprints on the viral DNA ends in moloney murine leukemia virus preintegration complexes reflect a specific association with integrase.

Authors:  S Q Wei; K Mizuuchi; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

9.  Mutations in the gag gene of Moloney murine leukemia virus: effects on production of virions and reverse transcriptase.

Authors:  P Schwartzberg; J Colicelli; M L Gordon; S P Goff
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

10.  Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses.

Authors:  L DesGroseillers; P Jolicoeur
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

View more
  82 in total

1.  Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.

Authors:  A Fassati; S P Goff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Use of a transient assay for studying the genetic determinants of Fv1 restriction.

Authors:  M Bock; K N Bishop; G Towers; J P Stoye
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Expression of Moloney murine leukemia virus RNase H rescues the growth defect of an Escherichia coli mutant.

Authors:  A G Campbell
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Underrepresentation of the 3' region of the capsid pregenomic RNA of duck hepatitis B virus.

Authors:  Kristin M Ostrow; Daniel D Loeb
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

5.  Structure of the Brd4 ET domain bound to a C-terminal motif from γ-retroviral integrases reveals a conserved mechanism of interaction.

Authors:  Brandon L Crowe; Ross C Larue; Chunhua Yuan; Sonja Hess; Mamuka Kvaratskhelia; Mark P Foster
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

6.  Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteins.

Authors:  Jennifer Puglia; Tan Wang; Christine Smith-Snyder; Marie Cote; Michael Scher; Joelle N Pelletier; Sinu John; Colleen B Jonsson; Monica J Roth
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

7.  High-throughput, library-based selection of a murine leukemia virus variant to infect nondividing cells.

Authors:  Julie H Yu; David V Schaffer
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Isolation, characterization, and genetic complementation of a cellular mutant resistant to retroviral infection.

Authors:  Sumit Agarwal; Josephine Harada; Jeffrey Schreifels; Patrycja Lech; Bryan Nikolai; Tomoyuki Yamaguchi; Sumit K Chanda; Nikunj V Somia
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

9.  Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor.

Authors:  Matthew Stremlau; Michel Perron; Mark Lee; Yuan Li; Byeongwoon Song; Hassan Javanbakht; Felipe Diaz-Griffero; Donovan J Anderson; Wesley I Sundquist; Joseph Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-15       Impact factor: 11.205

10.  Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription.

Authors:  Luca D Passerini; Zuzana Keckesova; Greg J Towers
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.